Anthem Biosciences IPO GMP, Open Date, Price Band, DRHP Filed

Anthem Biosciences IPO GMP will be available once the IPO is open for subscription. Anthem Biosciences files DRHP to SEBI for its upcoming IPO. This IPO's open date is expected to be in mid-April 2025. This upcoming IPO is a book-built issue offering entirely an Offer for Sale. The company is offering worth up to Rs 3,395 crore of equity shares as an Offer for Sale, there is no fresh issue included in this IPO.

Also Read | Gem Aromatics IPO GMP, Open Date, Price Band, DRHP Filed

Anthem Biosciences IPO GMP

Anthem Biosciences IPO GMP has not yet started. The IPO GMP today indicates the interest of retail investors in the IPO. You can check the latest IPO Grey Market Premium today online from the first day of subscription. If the subscription is oversubscribed, then Anthem Biosciences IPO GMP might rise in the coming days.

Anthem Biosciences IPO GMP Live status will indirectly impact the sentiments of the IPO investors. If the Grey Market Premium is quoting at 10% or above, then the possibility of the oversubscription increases. 

However, if the Live IPO GMP quotes are 10% or below the premium, then most investors tend to lose interest in applying for the IPO and the probability of the under-subscription increases. Here, in the Anthem Biosciences IPO, GMP is expected to quote the initial ticks at a premium of 16% or above.

Anthem Biosciences IPO Open Date, Close Date

Anthem Biosciences IPO's open date and close date are expected to be in mid-April 2025. However, as of now, the open and close date has not yet been finalised.

Anthem Biosciences IPO Price Band

Anthem Biosciences IPO price band will be available soon. The minimum amount of investment for the retail category is to be around Rs 14,800, and for small HNI, the minimum investment will be around Rs 2,07,200.

Anthem Biosciences IPO Issue Size

Anthem Biosciences IPO issue size is worth up to Rs 3,395 crore of equity shares, entirely as an Offer for Sale; there will be no fresh issue part included in this IPO. The total number of equity shares that will be issued in this IPO has not yet been disclosed, whereas the total aggregate size of this IPO in rupees is Rs 3,395 crore.

Anthem Biosciences IPO Allotment Status

Anthem Biosciences IPO allotment status will be available once the IPO is available for subscription. The listing will be on the BSE and NSE platforms. The registrar of this IPO is KFin Technologies Limited. Investors can check their allotment status after the subscription of the IPO ends.

Anthem Biosciences IPO Listing Date

Anthem Biosciences IPO's listing date will be available soon. The listing will be on BSE and NSE platforms. Retail investors can sell the shares after 10 AM on the listing day.

Anthem Biosciences IPO: Listing Date, Lot Size, Price Band

Anthem Biosciences Limited: About the Company

Anthem Biosciences Limited, established in 2006 in Bangalore, India, is a major Contract Research and Development Organization (CRDMO). 

The company specialises in drug discovery, development, and manufacturing services, catering to large pharmaceutical firms globally. The company has a team of over 1,200 scientists. Anthem offers a various range of services including medicinal chemistry, process development, and analytical research.

Their facilities are equipped with advanced technology and have received approvals from regulatory bodies such as the USFDA and TGA. Anthem has demonstrated strong financial health, characterised by impressive margins and liquidity.

As it continues to expand its capabilities, Anthem remains committed to innovation and quality in the biopharmaceutical sector, ensuring timely delivery and compliance with industry standards.

Anthem Biosciences IPO Objectives

Since the offer is an Offer for Sale, the company will not receive any proceeds from the offer. The funds received from IPO will get directly credited to the bank account of the respective selling shareholders.

Anthem Biosciences IPO: Key Dates, Allotment, Listing Date

Anthem Biosciences Financials

Anthem Biosciences Limited posted revenue of Rs 1,419.37 crore and a net profit of Rs 1,056.92 crore for the period ending on March 31, 2024. The company's revenue increased by 34.29 between the FY ending on March 31, 2024, and March 31, 2023. 

Anthem Biosciences IPO Subscription Details, IPO Reservation

Anthem Biosciences IPO subscription details will be available soon. Anthem Biosciences IPO reservation is as follows: not more than 50% of the offer is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for retail investors is reserved.

Anthem Biosciences IPO Lot Size Details

Anthem Biosciences IPO lot size will be revealed soon. The minimum amount of investment for the retail category is to be around Rs 14,800, and for small HNI, the minimum investment will be around Rs 2,07,200.

Anthem Biosciences IPO Promoter Holdings

Anthem Biosciences promoters are Ajay Bhardwaj, Ganesh Sambasivam, K Ravindra Chandrappa And Ishaan Bhardwaj. The promoters' shareholdings before the IPO were 71.11%; however, after the IPO, shareholdings will decline.

Anthem Biosciences IPO Registrar

Anthem Biosciences IPO registrar is KFin Technologies Limited. On the date of allotment, investors can click on the registrar's website, select the name of the company, and enter their PAN number or application ID to learn their allotment status.

Anthem Biosciences IPO Lead Managers

Anthem Biosciences IPO lead manager(s) are JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, Nomura Financial Advisory and Securities (India) Private Limited.

How to apply to Anthem Biosciences IPO

Interested investors can apply to the Anthem Biosciences IPO directly from the Bigul trading app by clicking here. Investors can also check the details of other upcoming IPO in Bigul.

Anthem Biosciences IPO FAQ

1. What are the details of the Anthem Biosciences IPO?

Anthem Biosciences IPO is a book-built issue offering an entirely an Offer for Sale of up to 3,395 crore equity shares.

2. When will the Anthem Biosciences IPO open and close?

Anthem Biosciences IPO's open date is expected to be in mid-April 2025. However, as of now, the open and close date has not yet been finalised.

3. What is Anthem Biosciences IPO GMP?

Anthem Biosciences IPO GMP quotation is not yet available. You can check the latest GMP price online and reliable GMP once the subscription starts. If the subscription is oversubscribed, then Anthem Biosciences IPO GMP will also rise.

4. What are the details of the Anthem Biosciences IPO reservation?

Anthem Biosciences IPO subscription details will be available soon. Anthem Biosciences IPO reservation is as follows: not more than 50% of the offer is reserved for Qualified Institutional Buyers (QIBs), not less than 15% for Non-Institutional Investors (NIIs), and not less than 35% for retail investors is reserved.

5. Write the details of the IPO Allotment Status.

Anthem Biosciences IPO allotment status will be available once the IPO is available for subscription. The listing will be on the BSE and NSE platforms. The registrar of this IPO is KFin Technologies Limited. Investors can check their allotment status after the subscription of the IPO ends.

6. Who is the registrar and the lead managers for Anthem Biosciences IPO?

Anthem Biosciences IPO registrar is KFin Technologies Limited. On the date of allotment, investors can click on the registrar's website, select the name of the company, and enter their PAN number or application ID to learn their allotment status. The lead manager(s) of JM Financial Limited, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, Nomura Financial Advisory and Securities (India) Private Limited.

Also Read:

• What is DRHP?
• What is IPO GMP?
• What is IPO?